138 related articles for article (PubMed ID: 37984556)
21. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis.
Biyun L; Yahui H; Yuanfang L; Xifeng G; Dao W
Clin Microbiol Infect; 2024 May; 30(5):601-610. PubMed ID: 38280518
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting.
Busca A; Passera R; Maffini E; Festuccia M; Brunello L; Dellacasa CM; Aydin S; Frairia C; Manetta S; Butera S; Iovino G; Giaccone L; Sorror M; Storb R; De Rosa FG; Bruno B
Bone Marrow Transplant; 2018 Oct; 53(10):1304-1310. PubMed ID: 29654289
[TBL] [Abstract][Full Text] [Related]
25. Allogenic Hematopoietic Stem Cell Transplantation Is Feasible in Pediatric Patients with an Active or Recently Diagnosed Invasive Fungal Infection.
Rotte LGY; Loeffen YGT; Bierings MB; Wolfs TFW; Lindemans CA
Transplant Cell Ther; 2021 Sep; 27(9):781.e1-781.e5. PubMed ID: 34153502
[TBL] [Abstract][Full Text] [Related]
26. Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
Little JS; Aleissa MM; Beluch K; Gonzalez-Bocco IH; Marty FM; Manne-Goehler J; Koo S; Hammond SP; Jacobson CA
Blood Adv; 2022 Aug; 6(16):4821-4830. PubMed ID: 35802461
[TBL] [Abstract][Full Text] [Related]
27. Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
Oh SM; Byun JM; Chang E; Kang CK; Shin DY; Koh Y; Hong J; Kim TS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
Sci Rep; 2021 Nov; 11(1):22160. PubMed ID: 34773060
[TBL] [Abstract][Full Text] [Related]
28. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
[TBL] [Abstract][Full Text] [Related]
29. Frequency and Determinants of Invasive Fungal Infections in Children With Solid and Hematologic Malignancies in a Nonallogeneic Stem Cell Transplantation Setting: A Narrative Review.
Ruijters VJ; Oosterom N; Wolfs TFW; van den Heuvel-Eibrink MM; van Grotel M
J Pediatr Hematol Oncol; 2019 Jul; 41(5):345-354. PubMed ID: 30973485
[TBL] [Abstract][Full Text] [Related]
30. Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients.
Vázquez L; Salavert M; Gayoso J; Lizasoaín M; Ruiz Camps I; Di Benedetto N;
Rev Esp Quimioter; 2017 Apr; 30(2):103-117. PubMed ID: 28198173
[TBL] [Abstract][Full Text] [Related]
31. High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia.
Wang ST; Chou CH; Chen TT; Lin CC; Bai LY; Yeh SP; Ho MW; Lien MY
Front Cell Infect Microbiol; 2022; 12():1012334. PubMed ID: 36530436
[TBL] [Abstract][Full Text] [Related]
32. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
33. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes.
Nganthavee V; Phutthasakda W; Atipas K; Tanpong S; Pungprasert T; Dhirachaikulpanich D; Krithin S; Tanglitanon S; Jutidamronphang W; Owattanapanich W; Chayakulkeeree M; Phikulsod P
Support Care Cancer; 2019 Sep; 27(9):3613-3622. PubMed ID: 31165931
[TBL] [Abstract][Full Text] [Related]
34. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
[TBL] [Abstract][Full Text] [Related]
36. The D-index is not correlated with invasive fungal infection during the early-post engraftment phase among allogeneic hematopoietic stem cell transplant recipients.
Abad CLR; Lahr B; O'Horo JC; Vijayvargiya P; Walker RC; Hogan WJ; Tande AJ
Int J Hematol; 2020 Feb; 111(2):293-302. PubMed ID: 31709502
[TBL] [Abstract][Full Text] [Related]
37. Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.
Christen D; Sohlbach K; Metzelder SK; Wollmer E; Hoeffkes HG; Naumann R; Burchardt A; Rummel M; Trenker C; Dohse M; Mack E; Klameth A; Mann C; Kostrewa P; Brendel C; Wündisch T; Neubauer A; Wilhelm C; Burchert A
Leuk Lymphoma; 2019 Aug; 60(8):2056-2061. PubMed ID: 30644334
[TBL] [Abstract][Full Text] [Related]
38. Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections.
Monzó-Gallo P; Chumbita M; Lopera C; Aiello TF; Peyrony O; Bodro M; Herrera S; Sempere A; Fernández-Pittol M; Cuesta G; Simó S; Benegas M; Fortuny C; Mensa J; Soriano A; Puerta-Alcalde P; Marco F; Garcia-Vidal C
Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36861308
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic SCT in patients with a history of invasive fungal infection.
Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Invasive Fungal Infection in Children and Adolescents With Hematologic and Malignant Diseases: A 10-year Analysis in a Single Institute in Japan.
Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
Pediatr Infect Dis J; 2018 Dec; 37(12):1282-1285. PubMed ID: 30408007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
